Apelin and energy metabolism

Frontiers in Physiology

Volumn 6, Issue MAR, 2015, Pages

  Bertrand, Chantal ^a,b   Valet, Philippe ^a,b   Castan Laurell, Isabelle ^a,b  

^a INSERM   (France)

^b University Hospital of Toulouse   (France)

Author keywords

Adipokine; Apelin; Insulin sensitivity; Obesity; Type 2 diabetes

Indexed keywords

APELIN;

ARTICLE; DIABETES MELLITUS; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; THERMOGENESIS;

EID: 84926453559     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00115     Document Type: Article

References (39)

1. Alexiadou, K., A. Kokkinos, S. Liatis, D. Perrea, N. Katsilambros & N. Tentolouris (2012) Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration. Hormones (Athens), 11, 444-50.
2. Alfarano, C., C. Foussal, O. Lairez, D. Calise, C. Attane, R. Anesia, et al. (2015) Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin. Int J Obes (Lond), 39, 312-20.
3. Attane, C., D. Daviaud, C. Dray, R. Dusaulcy, M. Masseboeuf, D. Prevot, et al. (2011) Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. J Mol Endocrinol, 46, 21-8.
4. Attane, C., C. Foussal, S. Le Gonidec, A. Benani, D. Daviaud, E. Wanecq, et al. (2012) Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes, 61, 310-20.
5. Azizi, M., X. Iturrioz, A. Blanchard, S. Peyrard, N. De Mota, N. Chartrel, et al. (2008) Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol, 19, 1015-24.
6. Boucher, J., B. Masri, D. Daviaud, S. Gesta, C. Guigne, A. Mazzucotelli, et al. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology, 146, 1764-71.
7. Burcelin, R., W. Dolci & B. Thorens (2000) Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes, 49, 1635-42.
8. Castan-Laurell, I., C. Dray, C. Attane, T. Duparc, C. Knauf & P. Valet (2011) Apelin, diabetes, and obesity. Endocrine, 40, 1-9.
9. Chapman, N. A., D. J. Dupre & J. K. Rainey (2014) The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR. Biochem Cell Biol, 92, 431-40.
10. Delaere, F., C. Magnan & G. Mithieux (2010) Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab, 36, 257-62.
11. De Mota, N., A. Reaux-Le Goazigo, S. El Messari, N. Chartrel, D. Roesch, Dujardin, C., et al. (2004) Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 101, 10464-69.
12. Dray, C., C. Knauf, D. Daviaud, A. Waget, J. Boucher, M. Buleon, et al. (2008) Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab, 8, 437-45.
13. Dray, C., Y. Sakar, C. Vinel, D. Daviaud, B. Masri, L. Garrigues, et al. (2013) The intestinal glucose-apelin cycle controls carbohydrate absorption in mice. Gastroenterology, 144, 771-80.
14. Farooqi, I. S. & S. O'Rahilly (2014) 20 years of leptin: human disorders of leptin action. J Endocrinol, 223, T63-70.
15. Fukaya, M., A. Mizuno, H. Arai, K. Muto, T. Uebanso, K. Matsuo, et al. (2007) Mechanism of rapid-phase insulin response to elevation of portal glucose concentration. Am J Physiol Endocrinol Metab, 293, E515-22.
16. Guo, L., Q. Li, W. Wang, P. Yu, H. Pan, P. Li, et al. (2009) Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B. Endocr Res, 34, 142-54.
17. Habchi, M., L. Duvillard, V. Cottet, M. C. Brindisi, B. Bouillet, M. Beacco, et al. (2014) Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control. Clin Endocrinol (Oxf), 81, 696-701.
18. Heinonen, M. V., D. E. Laaksonen, T. Karhu, L. Karhunen, T. Laitinen, S. Kainulainen, et al. (2009) Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis, 19, 626-33.
19. Higuchi, K., T. Masaki, K. Gotoh, S. Chiba, I. Katsuragi, K. Tanaka, et al. (2007) Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology, 148, 2690-7.
20. Knauf, C., A. Drougard, A. Fournel, T. Duparc & P. Valet (2013) Hypothalamic actions of apelin on energy metabolism: new insight on glucose homeostasis and metabolic disorders. Horm Metab Res, 45, 928-34.
21. Krist, J., K. Wieder, N. Kloting, A. Oberbach, S. Kralisch, T. Wiesner, et al. (2013) Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts, 6, 57-69.
22. Lafontan, M. & N. Viguerie (2006) Role of adipokines in the control of energy metabolism: focus on adiponectin. Curr Opin Pharmacol, 6, 580-5.
23. Ma, W. Y., T. Y. Yu, J. N. Wei, C. S. Hung, M. S. Lin, Y. J. Liao, et al. (2014) Plasma apelin: A novel biomarker for predicting diabetes. Clin Chim Acta, 435, 18-23.
24. Masri, B., B. Knibiehler & Y. Audigier (2005) Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 17, 415-26.
25. O'Carroll, A. M., S. J. Lolait, L. E. Harris & G. R. Pope (2013) The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis. J Endocrinol, 219, R13-35.
26. Ringstrom, C., M. D. Nitert, H. Bennet, M. Fex, P. Valet, J. F. Rehfeld, et al. (2010) Apelin is a novel islet peptide. Regul Pept, 162, 44-51.
27. Roy, D., M. Perreault & A. Marette (1998) Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol, 274, E692-9.
28. Sawane, M., K. Kajiya, H. Kidoya, M. Takagi, F. Muramatsu & N. Takakura (2013) Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes, 62, 1970-80.
29. Sorhede Winzell, M., C. Magnusson & B. Ahren (2005) The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept, 131, 12-7.
30. Tatemoto, K., M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M. X. Zou, et al. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun, 251, 471-6.
31. Than, A., Y. Cheng, L. C. Foh, M. K. Leow, S. C. Lim, Y. J. Chuah, et al. (2012) Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol, 362, 227-41.
32. Tishinsky, J. M., L. E. Robinson & D. J. Dyck (2012) Insulin-sensitizing properties of adiponectin. Biochimie, 94, 2131-6.
33. Wattez, J. S., R. Ravallec, B. Cudennec, C. Knauf, P. Dhulster, P. Valet, et al. (2013) Apelin stimulates both cholecystokinin and glucagon-like peptide 1 secretions in vitro and in vivo in rodents. Peptides.
34. Wei, L., X. Hou & K. Tatemoto (2005) Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept, 132, 27-32.
35. Xu, S., P. Han, M. Huang, J. C. Wu, C. Chang, P. S. Tsao, et al. (2012) In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake. Peptides, 37, 320-6.
36. Yamamoto, T., Y. Habata, Y. Matsumoto, Y. Yasuhara, T. Hashimoto, H. Hamajyo, et al. (2011) Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle. Biochim Biophys Acta, 1810, 853-62.
37. Yue, P., H. Jin, M. Aillaud, A. C. Deng, J. Azuma, T. Asagami, et al. (2010) Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab, 298, E59-67.
38. Yue, P., H. Jin, S. Xu, M. Aillaud, A. C. Deng, J. Azuma, et al. (2011) Apelin Decreases Lipolysis via Gq, Gi, and AMPK-Dependent Mechanisms. Endocrinology. 152, 59-68.
39. Zhu, S., F. Sun, W. Li, Y. Cao, C. Wang, Y. Wang, et al. (2011) Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem, 353, 305-13.